RENNOVA IS PLEASED TO REPORT IT HAS CLOSED THE AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP. (OTC: VMCS) June 28, 2021
RENNOVA CONTINUES TO WORK TO CLOSE THE AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP. (OTC: VMCS) June 3, 2021
RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP. May 17, 2021
RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) [UPDATED] January 6, 2021
RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS OFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) January 6, 2021
RENNOVA HEALTH, INC. TO DEPLOY RAPID COVID-19 TEST AT TWO HOSPITALS IN TENNESSEE AND RURAL CLINIC IN KENTUCKY September 14, 2020
RENNOVA HEALTH, INC. COMPLETES AGREEMENT TO SELL ITS WEST PALM BEACH BASED CLINICAL LABORATORY September 9, 2020
RENNOVA HEALTH, INC. ANNOUNCES APPROXIMATELY $19.3 MILLION OF A REDUCTION IN SECURED DEBENTURES September 2, 2020